# Ozone Auto-hemotherapy for COVID-19 Pneumonia

> **NCT04370223** · PHASE3 · UNKNOWN · sponsor: **Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta** · enrollment: 208 (estimated)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **BIOLOGICAL:** Ozone auto-hemotherapy

## Key facts

- **NCT ID:** NCT04370223
- **Lead sponsor:** Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-25
- **Primary completion:** 2020-10-25
- **Final completion:** 2020-12-25
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2020-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04370223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04370223, "Ozone Auto-hemotherapy for COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04370223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*